Flamel Technologies SA (FLML) CEO Michael S. Anderson Purchases 2,000 Shares
Flamel Technologies SA (NASDAQ:FLML) CEO Michael S. Anderson acquired 2,000 shares of the firm’s stock in a transaction that occurred on Monday, November 21st. The shares were purchased at an average cost of $10.64 per share, for a total transaction of $21,280.00. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
Michael S. Anderson also recently made the following trade(s):
- On Friday, September 2nd, Michael S. Anderson acquired 2,000 shares of Flamel Technologies SA stock. The shares were purchased at an average cost of $14.12 per share, for a total transaction of $28,240.00.
Shares of Flamel Technologies SA (NASDAQ:FLML) traded up 0.048% during midday trading on Wednesday, hitting $10.475. The stock had a trading volume of 43,494 shares. Flamel Technologies SA has a 52-week low of $7.56 and a 52-week high of $15.54. The company’s 50 day moving average is $0.00 and its 200 day moving average is $0.00.
Flamel Technologies SA (NASDAQ:FLML) last released its quarterly earnings data on Monday, November 7th. The company reported ($0.11) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.24) by $0.13. The firm earned $32.10 million during the quarter, compared to analyst estimates of $30.70 million. Flamel Technologies SA had a return on equity of 19.35% and a net margin of 18.25%. The business’s quarterly revenue was down 32.1% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.28 earnings per share. Analysts anticipate that Flamel Technologies SA will post ($1.41) earnings per share for the current fiscal year.
FLML has been the topic of a number of research reports. JMP Securities reissued an “outperform” rating and set a $16.00 price objective on shares of Flamel Technologies SA in a report on Wednesday, September 28th. Leerink Swann restated an “outperform” rating and set a $16.00 price target on shares of Flamel Technologies SA in a research report on Tuesday, September 27th. Finally, Zacks Investment Research upgraded Flamel Technologies SA from a “hold” rating to a “buy” rating and set a $14.00 price target on the stock in a research report on Tuesday, October 18th. Two investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. The company has an average rating of “Buy” and a consensus price target of $17.70.
Institutional investors have recently added to or reduced their stakes in the company. Janus Capital Management LLC raised its position in Flamel Technologies SA by 647.0% in the second quarter. Janus Capital Management LLC now owns 2,197,404 shares of the company’s stock worth $25,599,000 after buying an additional 1,903,256 shares during the period. Acadian Asset Management LLC increased its stake in Flamel Technologies SA by 240.2% in the second quarter. Acadian Asset Management LLC now owns 1,617,223 shares of the company’s stock worth $17,372,000 after buying an additional 1,141,783 shares in the last quarter. Emerald Acquisition Ltd. purchased a new stake in Flamel Technologies SA during the second quarter worth approximately $6,530,000. Ghost Tree Capital LLC purchased a new stake in Flamel Technologies SA during the second quarter worth approximately $3,759,000. Finally, Brown Capital Management LLC increased its stake in Flamel Technologies SA by 36.5% in the second quarter. Brown Capital Management LLC now owns 790,206 shares of the company’s stock worth $8,487,000 after buying an additional 211,392 shares in the last quarter. 69.99% of the stock is owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY NOTICE: This article was originally published by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are reading this article on another website, it was stolen and reposted in violation of U.S. and international copyright law. The original version of this article can be viewed at https://www.thecerbatgem.com/2016/11/23/flamel-technologies-sa-flml-ceo-michael-s-anderson-purchases-2000-shares.html.
Flamel Technologies SA Company Profile
Flamel Technologies SA is a specialty pharmaceutical company. The Company is engaged in the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its polymer based technology. The Company has a balanced business model consisting of an Unapproved Marketed Drugs (UMDs) business with over two approved products in the United States, Bloxiverz (neostigmine methylsulfate injection) and Vazculep (phenylephrine hydrochloride injection) that are marketed; a branded pediatric business, and a branded business, focusing on the development of products utilizing Flamel’s drug delivery platforms.
Receive News & Stock Ratings for Flamel Technologies SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Flamel Technologies SA and related stocks with our FREE daily email newsletter.